| Value | ₹3,094 Cr |
|---|---|
| Execution period | mid-2030 |
NSE filing, NSE: GRASIM. Summary written from the filing by ALFA Finder's alert engine.
Grasim Industries Ltd: key numbers
- Share price
- ₹2,922.80
- Market cap
- ₹1,98,903 Cr
- Revenue (annual)
- ₹1,75,431 Cr
- Net profit (annual)
- ₹4,966 Cr
- P/E (TTM)
- 34.9×Sector 31.3×
- Promoter holding
- 45.20%+1.46% QoQ
- FII holding
- 14.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Grasim Industries Ltd
All →Grasim Industries Debt & Borrowing: ₹750 Cr
Grasim Industries repaid ₹750 Crore of Commercial Paper (ISIN INE047A14BE6) at maturity on 26 Oct 2026. Outstanding CP amount is now Nil.
- Value
- ₹750.0 Cr
Grasim Industries Legal & Regulatory
Grasim replied to exchange queries on a news item. The Bombay HC quashed the Rs 329 crore reassessment notice, with no demand or financial impact.
Grasim Industries Production Started
Grasim Industries has commenced commercial production at its Epichlorohydrin plant in Vilayat, Gujarat, with a capacity of 50 K TPA. This strengthens its downstream chlor-alkali derivatives portfolio.
- epichlorohydrin (ECH) manufacturing capacity
- 50000 TPA
Grasim Industries Other Announcement
Grasim Industries Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI listing regulations.
Grasim Industries Debt & Borrowing
Grasim Industries submitted its half-yearly statement of outstanding Non-Convertible Debentures as of 30th September 2026, complying with SEBI circular requirements for debt securities.
Grasim Industries Other Announcement
Grasim Industries filed a CFO certificate confirming the utilization of proceeds from commercial papers issued during the quarter ended 30th September 2026.
Other capacity expansion announcements
All →Greenply Industries Capacity Expansion: ₹30 Cr Investment
Greenply's board approved further investment of up to INR 30 crore in its wholly owned subsidiary Greenply Sandila Private Limited for plywood capacity expansion. The funds will be paid in one or more tranches by Q4 FY2028.
- Value
- ₹30.00 Cr
- Execution
- Q4 of FY 2028, in one or more tranches
Ethos Capacity Expansion
Ethos has opened a new Ethos Summit boutique at Fort, Mumbai, taking its total to 105 boutiques across India. The filing is an update on a store opening with no monetary value disclosed.
- new boutiques
- 1.0 boutiques
Greenply Industries Capacity Expansion
Greenply's board noted a 15 million sq mtr plywood capacity expansion at subsidiary Greenply Sandila, due by Q4 FY2028. Approximately Rs. 125 crore investment is planned.
- Execution
- By Q4 of FY 2028
- plywood manufacturing capacity
- 15.0 million sq mtr
Senores Pharmaceuticals Capacity Expansion: ₹20 Cr Investment
Senores Pharmaceuticals' subsidiary Apnar Pharma Private Limited plans a 0.7 Bn unit capacity addition by March 2027. The investment is Rs.20.00 Crore, funded by internal accruals and IPO proceeds.
- Value
- ₹20.00 Cr
- Execution
- By end of March 2027
- production capacity
- 0.7 Bn units
Senores Pharmaceuticals Capacity Expansion: ₹18 Cr Investment
Senores Pharmaceuticals plans to add 0.8 Bn units of capacity to its existing 1.2 Bn unit plant by March 2027. The investment is Rs.18.00 Crore, funded by internal accruals and IPO proceeds.
- Value
- ₹18.00 Cr
- Execution
- By end of March 2027
- production capacity
- 0.8 Bn units
EPack Prefab Technologies Capacity Expansion: ₹100 Cr Investment
EPack Prefab plans to add 11,300 MT of PEB and 8,00,000 sq m of PUF capacity. The ₹100 Crore investment will be funded from IPO proceeds.
- Value
- ₹100.0 Cr
- Execution
- Period stated as 28-10-2026 in the filing (date as filed; the period is not otherwise defined)
- PEB structures capacity addition
- 11300.0 MTPA